Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. more
Time Frame | TECH | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.49% | -0.94% | -2.6% |
1-Month Return | -2.22% | -5.08% | -1.08% |
3-Month Return | -5.79% | -10.62% | 3.45% |
6-Month Return | -2.35% | -6.18% | 8.57% |
1-Year Return | -6.67% | 1.98% | 24.3% |
3-Year Return | -41.18% | -0.93% | 25.58% |
5-Year Return | 31.25% | 33.84% | 84.07% |
10-Year Return | 212.02% | 102.52% | 185.12% |
Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 738.69M | 931.03M | 1.11B | 1.14B | 1.16B | [{"date":"2020-06-30","value":63.73,"profit":true},{"date":"2021-06-30","value":80.33,"profit":true},{"date":"2022-06-30","value":95.39,"profit":true},{"date":"2023-06-30","value":98.07,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Cost of Revenue | 255.50M | 298.18M | 349.10M | 366.89M | 389.33M | [{"date":"2020-06-30","value":65.62,"profit":true},{"date":"2021-06-30","value":76.59,"profit":true},{"date":"2022-06-30","value":89.67,"profit":true},{"date":"2023-06-30","value":94.23,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Gross Profit | 483.19M | 632.85M | 756.50M | 769.82M | 769.73M | [{"date":"2020-06-30","value":62.77,"profit":true},{"date":"2021-06-30","value":82.21,"profit":true},{"date":"2022-06-30","value":98.27,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":99.99,"profit":true}] |
Gross Margin | 65.41% | 67.97% | 68.42% | 67.72% | 66.41% | [{"date":"2020-06-30","value":95.6,"profit":true},{"date":"2021-06-30","value":99.34,"profit":true},{"date":"2022-06-30","value":100,"profit":true},{"date":"2023-06-30","value":98.98,"profit":true},{"date":"2024-06-30","value":97.06,"profit":true}] |
Operating Expenses | 325.77M | 395.55M | 459.91M | 470.87M | 563.04M | [{"date":"2020-06-30","value":57.86,"profit":true},{"date":"2021-06-30","value":70.25,"profit":true},{"date":"2022-06-30","value":81.68,"profit":true},{"date":"2023-06-30","value":83.63,"profit":true},{"date":"2024-06-30","value":100,"profit":true}] |
Operating Income | 74.68M | 149.55M | 296.59M | 298.94M | 206.69M | [{"date":"2020-06-30","value":24.98,"profit":true},{"date":"2021-06-30","value":50.03,"profit":true},{"date":"2022-06-30","value":99.21,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":69.14,"profit":true}] |
Total Non-Operating Income/Expense | 183.20M | (102.60M) | (5.72M) | 31.91M | (33.41M) | [{"date":"2020-06-30","value":100,"profit":true},{"date":"2021-06-30","value":-56,"profit":false},{"date":"2022-06-30","value":-3.12,"profit":false},{"date":"2023-06-30","value":17.42,"profit":true},{"date":"2024-06-30","value":-18.24,"profit":false}] |
Pre-Tax Income | 276.48M | 148.18M | 301.39M | 338.66M | 185.69M | [{"date":"2020-06-30","value":81.64,"profit":true},{"date":"2021-06-30","value":43.75,"profit":true},{"date":"2022-06-30","value":88.99,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":54.83,"profit":true}] |
Income Taxes | 47.18M | 8.59M | 38.29M | 53.22M | 17.58M | [{"date":"2020-06-30","value":88.66,"profit":true},{"date":"2021-06-30","value":16.14,"profit":true},{"date":"2022-06-30","value":71.95,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":33.04,"profit":true}] |
Income After Taxes | 229.30M | 139.59M | 263.10M | 285.44M | 168.10M | [{"date":"2020-06-30","value":80.33,"profit":true},{"date":"2021-06-30","value":48.9,"profit":true},{"date":"2022-06-30","value":92.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.89,"profit":true}] |
Income From Continuous Operations | 229.30M | 139.59M | 263.10M | 285.44M | 168.10M | [{"date":"2020-06-30","value":80.33,"profit":true},{"date":"2021-06-30","value":48.9,"profit":true},{"date":"2022-06-30","value":92.17,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.89,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2020-06-30","value":"-","profit":true},{"date":"2021-06-30","value":"-","profit":true},{"date":"2022-06-30","value":"-","profit":true},{"date":"2023-06-30","value":"-","profit":true},{"date":"2024-06-30","value":"-","profit":true}] |
Net Income | 229.30M | 140.41M | 272.05M | 285.26M | 168.10M | [{"date":"2020-06-30","value":80.38,"profit":true},{"date":"2021-06-30","value":49.22,"profit":true},{"date":"2022-06-30","value":95.37,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":58.93,"profit":true}] |
EPS (Diluted) | 1.14 | 1.69 | 1.98 | 2.00 | 1.78 | [{"date":"2020-06-30","value":57,"profit":true},{"date":"2021-06-30","value":84.5,"profit":true},{"date":"2022-06-30","value":99,"profit":true},{"date":"2023-06-30","value":100,"profit":true},{"date":"2024-06-30","value":89,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
TECH | |
---|---|
Cash Ratio | 1.32 |
Current Ratio | 4.56 |
Quick Ratio | 3.26 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TECH | |
---|---|
ROA (LTM) | 5.55% |
ROE (LTM) | 7.29% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TECH | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.22 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.78 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TECH | |
---|---|
Trailing PE | 77.02 |
Forward PE | 38.76 |
P/S (TTM) | 9.92 |
P/B | 5.44 |
Price/FCF | 212 |
EV/R | 10.11 |
EV/Ebitda | 39.39 |
PEG | 2.69 |
Bio-Techne Corp (TECH) share price today is $72.74
Yes, Indians can buy shares of Bio-Techne Corp (TECH) on Vested. To buy Bio-Techne Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TECH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Bio-Techne Corp (TECH) via the Vested app. You can start investing in Bio-Techne Corp (TECH) with a minimum investment of $1.
You can invest in shares of Bio-Techne Corp (TECH) via Vested in three simple steps:
The 52-week high price of Bio-Techne Corp (TECH) is $85.39. The 52-week low price of Bio-Techne Corp (TECH) is $60.97.
The price-to-earnings (P/E) ratio of Bio-Techne Corp (TECH) is 75.433
The price-to-book (P/B) ratio of Bio-Techne Corp (TECH) is 5.44
The dividend yield of Bio-Techne Corp (TECH) is 0.44%
The market capitalization of Bio-Techne Corp (TECH) is $11.63B
The stock symbol (or ticker) of Bio-Techne Corp is TECH